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Since February 2009, there has been 
limited supply of pediatric monovalent 
hepatitis B vaccine nationally.  Despite 
these supply constraints, CDC has 
determined there is sufficient 
pediatric hepatitis B vaccine available 
to continue the current hepatitis B 
recommendations for the remainder 
of 2009.  However, providers will 
need to order hepatitis B containing 
vaccine judiciously to ensure there is 
sufficient product available for all 
providers.  
At this time, providers should continue to 
administer pediatric hepatitis B vaccine 
according to the ACIP/AAP/AAFP 2009 
childhood immunization schedule, 
including giving the hepatitis B birth dose. 
Given the current situation with the supply 
of pediatric hepatitis B vaccine, providers 
should not combine two pediatric doses of 
hepatitis B (Merck, Recombivax HB allows 
this practice) to vaccinate an adult patient 
(>19 years old), doing so will diminish 
doses that are available for patients 19 
and younger, especially high-risk infants 
born to HBsAg-positive mothers.  
Vaccines for Children (VFC) Program 
providers should order pediatric hepatitis B 
vaccine monthly and only order enough 
vaccine to cover their needs for a 30-day 
period.  In order to assure equitable 
vaccine distribution throughout the VFC 
Program, the CDC has set monthly 
allocation limits for the number of Hep B 
vaccine doses each state will receive.  
Similar limitations are being put in place 
for private sector orders.  
CDC has worked with both Merck and GSK, 
the two manufacturers of pediatric 
monovalent hepatitis B vaccine, to 
determine how much vaccine will be 
available for the remainder of 2009.  
Merck expects to have a very limited 
supply and GSK plans to provide additional 
vaccine by September or October 2009. 
Vaccine supply is anticipated to be very 
tight during the summer months.   
Questions regarding the VFC hepatitis B 
vaccine supply should be directed to 
Janean Iddings or Tina Patterson at 800-
831-6293 ext 5 and 4, respectively.  
Contact Bridget Konz, at 800-831-6293 
ext. 7 with questions regarding the 
hepatitis B birth dose.   
A chart showing how to protect infants 
against hepatitis B virus infection when 
using Pentacel vaccine during the Hib 
vaccine shortage, can be found at the 
following CDC Web site: 
http://www.cdc.gov/vaccines/vac-
gen/shortages/downloads/eo-hib-hepb-
cov.pdf 
 
unization Program
The Pink Book is Now Available: The 11th Edition of the Epidemiology and 
Prevention of Vaccine-Preventable Diseases, (The Pink Book) published by 
the National Immunization Program, Centers for Disease Control and 
Prevention, is now available.  The Pink Book provides physicians, nurses, 
nurse practitioners, physician assistants, pharmacists, and others with the 
most comprehensive information on vaccine-preventable diseases. 
For more information on how to order a Pink Book, or to view chapters and 
index online, go to: 
http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm 
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On December 13, 2007, certain lots 
of Haemophilus influenzae type b 
(Hib) vaccine marketed as 
PedvaxHIB (monovalent Hib vaccine) 
and Comvax (Hib-HepB vaccine) 
manufactured by Merck, were 
recalled voluntarily, and the company 
temporarily suspended production of 
these vaccines. To conserve the 
limited supply of Hib-containing 
vaccines, CDC, in consultation with 
the ACIP, AAFP, and AAP, on 
December 18, 2007, recommended 
that vaccination providers 
temporarily defer the routine Hib 
vaccine booster dose administered to 
most healthy children at age 12 
through 15 months. 
Production of Merck Hib vaccine 
products is still suspended. However, 
two other Hib-containing vaccines 
manufactured by Sanofi Pasteur - 
monovalent Hib vaccine (ActHIB) and 
DTaP-IPV/Hib (Pentacel) - have been 
available for use in the United States 
during this shortage. Beginning in 
July 2009, Sanofi will increase the 
number of doses of these two 
products available for use in the 
United States, which will result in the 
supply being sufficient to reinstate 
the Hib vaccine booster dose. 
Effective immediately, CDC, in 
consultation with ACIP, AAFP, 
and AAP, is recommending 
reinstatement of the booster 
dose of Hib vaccine for children 
aged 12 through 15 months who 
have completed the primary 3-
dose series.  
Infants should continue to receive 
the primary Hib vaccine series at 
ages 2, 4 and 6 months. Children age 
12 through 15 months should receive 
the booster dose on time.  
Older children for whom the booster 
dose was deferred should receive 
their Hib booster dose at the next 
routinely scheduled visit or medical 
encounter. Although supply is 
sufficient to reinstate the booster 
 dose and begin catch-up 
For example, if a provider is using 
DTaP-IPV/Hib (Pentacel) vaccine to 
protect infants against Hib disease, 
the provider should ensure that 
adequate stock of monovalent HepB 
vaccine is available to complete the 
HepB vaccine series.* Children who 
need the Hib booster and who already 
have received four doses of DTaP 
should receive monovalent Hib 
vaccine (ActHIB) as their Hib booster 
dose. However, if DTaP-IPV/Hib is the 
only Hib-containing vaccine available, 
this combination product can be used 
to complete the series of Hib 
vaccination, even if the child already 
has received all the necessary doses 
of DTaP and IPV. 
Vaccination providers with questions 
about their supplies of monovalent 
Hib vaccine (ActHIB) or DTaP-IPV/Hib 
(Pentacel) purchased with nonpublic 
funds should contact Sanofi Pasteur's 
customer service department at 800-
822-2463. Sanofi Pasteur will work 
directly with physicians to increase 
allotments of Hib-containing vaccines 
on the basis of previous purchasing 
patterns or practice birth cohort and 
estimates of additional vaccine doses 
needed. For VFC vaccine supply, 
providers should contact the 
Immunization Program at 800-831-
6293.  
The Immunization Program is 
currently reviewing the Hib waiver for 
licensed child care centers and is 
planning to  extend the waiver until 
recommendations and vaccine supply 
is adequate to vaccinate all children 
with a deferred Hib booster dose.   
This recommendation reflects CDC's 
assessment of the existing national 
Hib vaccine supply and will be 
updated if the supply changes. 
Updated information about the 
national Hib vaccine supply is 
available at: 
http://www.cdc.gov/vaccines/vac-
gen/shortages/default.htm. 
Continued on page 3 
 
vaccination, supply is not yet ample 
enough to support a mass 
notification process to contact all 
children with deferred Hib booster 
doses. 
Sufficient vaccine will be available to 
administer the primary series at ages 
2, 4 and 6 months and a booster dose 
on time to children age 12 through 15 
months. As part of delivering the 
booster dose to those children for 
whom it was deferred to the next 
routinely scheduled appointment or 
medical encounter, practices should 
discuss with parents the reasons for 
the change in recommendation and 
might consider 1) reviewing electronic 
or paper medical records or 
immunization information system 
records to identify children in need of a 
booster dose before physician 
encounters, 2) evaluating children's 
vaccination status during their 
scheduled visit, and 3) sharing 
immunization schedules with parents 
to make them aware of this plan. 
 
 
 
 
 
During the Hib shortage, children 
received protection from certain 
vaccine preventable diseases in their 
primary vaccination series through 
combination vaccines (e.g., DTaP-
IPV/Hib [Pentacel] and DTaP-IPV-HepB 
[Pediarix]) and monovalent vaccines 
(e.g., ActHib, HepB, and IPV). 
Therefore, a mismatch might exist 
between patient vaccination needs and 
the available stock of different vaccine 
formulations (e.g., combination 
products versus single-antigen 
vaccines) in local provider offices. This 
situation presents a challenge for 
providers to administer vaccines to 
ensure appropriate coverage while 
minimizing extra doses of unneeded 
vaccine.  
IMMUNIZATION UPDATE: THE IOWA IMMUNIZATION PROGRAM NEWSLETTER JULY  2009 
HIB Booster Dose Reinstated 
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H1N1 Influenza 
Information 
As we near closer to our typical influenza 
season and the world learns more about 
H1N1 there are two sources of 
information that are reliable and easy to 
access.  The CDC H1N1 Web page is full 
of resources for providers and patients 
with easy downloads and plenty of 
guidance.  The Web page is found at: 
http://www.cdc.gov/h1n1flu/. 
The Iowa Department of Public Health’s 
H1N1 Web page and contains Iowa 
specific information is found at: 
http://www.idph.state.ia.us/h1n1/default
.asp  
The FDA is warning consumers regarding 
products related to the 2009 H1N1 flu 
virus offered on the Internet. The 
products involved are those that are 
promoted and marketed to diagnose, 
mitigate, prevent, treat or cure the 2009 
H1N1 flu virus but are not approved, 
cleared or authorized by the FDA.  To 
view the full press release: 
http://www.fda.gov/NewsEvents/Newsroo
m/PressAnnouncements/ucm166801.htm 
Details about the routine Hib schedule are 
available at: 
http://www.cdc.gov/vaccines/recs/schedule
s/default.htm#child.  
Adverse events following receipt of any 
vaccine should be reported to the Vaccine 
Adverse Event Reporting System (VAERS) 
at: http://vaers.hhs.gov. 
This article is printed directly from the CDC 
MMWR June 26, 2009 / 58(24);673-674 
and can be found at the following address:  
http://www.cdc.gov/mmwr/preview/mmwrh
tml/mm5824a5.htm?s_cid=mm5824a15e 
* Additional information available at 
http://www.cdc.gov/vaccines/vac-
gen/shortages/downloads/eo-hib-hepb-
cov.pdf. 
HIB Booster Dose Reinstated, continued 
Reminder from January 26, 2009  
VFC Memo 
 
The CDC released new VFC Program requirements to eliminate the use of 
dorm-style refrigerators as permanent (overnight) vaccine storage units for 
vaccine. Guidelines indicate dorm-style units should only be used to store a 
single-day supply of refrigerated vaccines as long as the unit temperatures 
are monitored and documented twice a day on temperature log specifically 
for that unit and vaccine is returned to the recommended storage unit at the 
end of the clinic day.   
Dormitory-style refrigerators are not adequate for long-term or permanent 
storage of biological products because they do not maintain appropriate 
temperatures.  A dormitory-style unit should never be used for storing 
Varicella-containing vaccines.   
A dorm-style refrigerator is defined as a small combination 
refrigerator/freezer unit that has one external door and an ice-maker/freezer  
compartment within the refrigerator.   
CDC requires all VFC providers who permanently store (overnight) 
vaccine in a dorm-style refrigerator to replace it with a 
recommended storage unit by December 31, 2009.   
The Immunization Program will be working with VFC Program providers 
throughout the upcoming year to comply with this new requirement.  If you 
have questions regarding this issue or the VFC Program, please contact Tina 
Patterson at 1-800-831-6293, ext. 4. 
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and a copy (either paper or 
electronic) to take home. Always 
offer the patient an opportunity to 
ask questions. [Note: When a 
combination 
vaccine is 
administered 
for which there 
is not a 
consolidated 
VIS, give the 
patient the 
individual VIS 
for each 
component.] 
2. It is 
acceptable to 
make a VIS 
available to be 
read before the 
immunization 
visit (e.g., by 
giving the 
patient or parent a copy to take 
home during a prior visit or telling 
them how to download or view a 
copy from the internet). We 
encourage this when possible. 
These patients must still be 
offered a copy to read during the 
immunization visit, as a reminder, 
and a copy to take home. 
3. The patient may be offered a 
permanent (e.g., laminated) copy 
of the VIS to read during the 
immunization visit (instead of 
their own paper copy), or may be 
directed to the appropriate VIS on 
an office computer. [Note: Check 
the CDC's VIS Web site 
Change in VIS Guidelines 
On June 17, 2009, the CDC updated 
the requirements for Vaccine 
Information Statements (VIS).  While 
providers are still required to provide 
VIS by federal law, 
there are innovative 
ways to comply 
with the VIS law 
while conserving 
paper.  
The legal mandate, 
as stated in the 
National Childhood 
Vaccine Injury Act, 
is that providers 
must give the 
appropriate VIS to 
the recipient or to 
the recipient’s 
parent or legal 
representative with 
each dose of 
vaccine; give it 
prior to administration of the vaccine; 
give it each time the vaccine is given 
(not just with the first dose), and 
record certain information in the 
patient’s permanent medical record.  
Within the context of this mandate, 
there are a variety of ways a VIS can 
now be offered.  The following list of 
options for providing VIS offers 
several ways clinics can meet the legal 
requirements.  Any one or 
combination of the following is 
acceptable:  
1. Always offer the patient or parent 
a copy of the appropriate VIS to 
read during the immunization visit 
periodically to ensure that the 
office copies you are using are the 
current editions.] 
4. Always encourage the patient to 
take a copy of each appropriate 
VIS home when they leave the 
office. This is because some 
information (e.g., the routine 
schedule, or how to recognize or 
report an adverse event) can be 
useful later. Offer the patient a 
paper copy, or if they prefer to 
download the VIS onto a mobile 
device, direct them to CDC's 
patient download Web page 
during the visit. 
http://www.cdc.gov/vaccines/pub
s/vis/vis-downloads.htm 
As needed, supplement VIS orally, 
with videotapes, with additional 
printed material, or in any other way 
that will help recipients understand 
the disease and vaccine.  Record the 
following required information on the 
patient's medical record or on a 
permanent office log (the record 
should be both permanent and 
accessible): 
1. The edition date of the VIS (found 
on the back in either the left or 
right bottom corner). [Note: 
When multiple VIS are given for a 
combination vaccine, record the 
individual edition dates.]  
2. The date the VIS is provided (i.e., 
the date of the visit when the 
vaccine is administered).  
   
 Continued on page 6 
New IRIS List Serve 
Subscribe to the new IRIS list serve! This service will provide you with timely 
information regarding changes, maintenance or new information about IRIS. To 
subscribe, send a blank email message to join-IRISUSERS@lists.ia.gov.  
Please share this new resource with your colleagues and fellow IRIS users who may 
wish to receive up to date information about IRIS. For questions about the IRIS list 
serve, please call the IRIS Help Desk at 800-374-3958.  The IRIS Program looks 
forward to serving you through this new process! 
Providers must give the appropriate VIS to the 
recipient or to the recipient’s parent or legal 
representative with each dose of vaccine 
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More than 600 hundred public 
health leaders, health care providers 
and immunization experts gathered 
in Des Moines on Wednesday and 
Thursday, June 10 and 11, 2009, for 
the Statewide Iowa Immunization 
Conference.  
Held every two years, the 
conference provides an opportunity 
for immunization professionals to 
hear from experts in the field and 
honor excellence among their peers. 
For the first time, an awards 
ceremony was held the evening 
before the conference and featured 
recognition of six recipients of 
Immunization Awards of Excellence 
for their commitment to 
immunizations and the health of 
Iowans. The honorees are as 
follows:  
 
 
 
 
 
Towncrest Pharmacy - The 
pharmacists at Towncrest Pharmacy 
in Iowa City use unique strategies 
to promote immunizations. Most 
notably, the pharmacists work with 
several community living 
organizations that care for adults 
and children with disabilities.  
Physical constraints prevent many 
of them from visiting the pharmacy 
or other health care providers for 
vaccinations. In response, the 
pharmacy developed a vaccination 
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2009 Immunization Conference a Success! 
service in which staff go to the 
individual’s home to provide 
immunizations. Towncrest Pharmacy 
has provided vaccines to over 7,500 
individuals over the last five years. 
 
 
 
 
 
Hancock County Public Health 
Department  As part of a required 
bio-emergency preparedness exercise, 
Hancock County conducted a mass 
vaccination clinic. Student 
immunization records were reviewed 
and qualifying teens were transported 
from local schools to receive the 
meningitis vaccine. The clinic provided 
information about how long a mass 
vaccination clinic would last in a real-
world situation, and students received 
needed immunizations. 
 
 
 
 
 
Linda Manders – A nurse at 
Davenport Public Schools, Linda was 
able to successfully implement a 
school-based vaccination clinic. Using 
student ambassadors and peer 
educators, Linda was able to build 
enthusiasm among the students for 
the clinic. Linda was instrumental in 
spreading the message that adolescent 
immunizations should be a priority. 
Brooke Grundman - Brooke is 
employed by Alegent Mercy Hospital in 
Corning, as the infection control nurse. 
One of her most successful campaigns 
was to increase the number of staff 
members at her hospital to receive the 
influenza vaccine. Brooke increased the 
percentage of employees receiving the 
flu vaccine from 75 percent in the fall of 
2007, to 86 percent in 2008. 
McFarland Clinic Pediatric 
Department - The staff at McFarland 
Pediatrics in Ames developed a 
cooperative staffing plan, offering flu 
vaccinations for patients before and 
after normal business hours without 
requiring additional staff time. More 
than 9,000 doses of flu vaccine were 
administered in the 2008-2009 season. 
Many of the vaccinations were given in 
these before and after hour clinics.  
Dr. Atkinson’s Sources of Information about Autism from the 2009 Immunization Conference  
During the 2009 Statewide Immunization Conference, Dr. Atkinson mentioned valuable resources to address parents concerns 
regarding immunization and autism.   Below are the sites he noted in his presentation.  Dr. Atkinson, and other speakers, 
presentations are available on the Immunization Program Web page:  http://www.idph.state.ia.us/adper/immunization.asp 
• Centers for Disease Control and Prevention Autism Information Center – www.cdc.gov/ncbddd/autism/index.htm 
• American Academy of Pediatrics – www.aap.org/healthtopics/autism.cfm 
• Vaccine Education Center at the Children’s Hospital of Philadelphia – www.chop.edu/consumer/your_child/index.jsp 
• Autism’s False Prophets, by Dr. Paul Offit– http://www.amazon.com/Autisms-False-Prophets-Science-Medicine/dp/0231146361 
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3. The name, address (office 
address) and title of the person 
who administers the vaccine.  
4. The date the vaccine is 
administered.  
5. The vaccine manufacturer and 
lot number.  
Providers May Also add a 
practice’s name, address, or phone 
number to an existing VIS. If the 
publication date is cut off during 
downloading, add the date. Have a 
recipient or their parent or legal 
representative sign a separate 
“informed consent” form if it is 
required by your agency. There is 
no federal requirement for written 
informed consent for vaccinations, 
and VIS are not considered 
informed consent forms, nor dose 
Iowa have such requirements.   
Providers Should Not change a 
VIS or make your own VIS. The law 
requires providers to use those 
developed by CDC. 
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Providers can still offer VIS the 
traditional way, with a provider giving 
the patient or parent a paper copy to 
read prior to the vaccination, and then 
encouraging them to take the same 
copy home with them.   Or one of 
several options above can be 
exercised.  As long as the 
patient/parent is 1) given the 
appropriate VIS to read prior to 
vaccination and 2) offered a copy, 
either paper or electronic, to take 
home, the federal legal requirements 
are satisfied.   
VIS will continue to be available at no 
cost through the Iowa Health 
Protection Clearinghouse and can be 
ordered directly from the Immunization 
Program Web page at 
http://www.idph.state.ia.us/adper/imm
unization_products.asp  For further 
information, visit the CDC Web site 
http://www.cdc.gov/vaccines/pubs/vis/
vis-facts.htm or contact Bridget Konz 
or Terri Thornton at 800-831-6293 ext. 
7 and 2, respectively.   
Ask the Experts 
Question: I accidentally gave 
Zostavax IM instead of SC. What do 
I need to do? 
 
Answer: You can count the dose as 
valid. ACIP recommends that 
vaccines given by the wrong route 
be counted as valid with one 
exception: hepatitis B administered 
by any route other than 
intramuscular should not be counted 
as valid and should be repeated. 
Vaccines should always be given by 
the route recommended by the 
manufacturer, but errors do occur. 
Your practice should put procedures 
in place to ensure that you give 
vaccines by the recommended route.  
 
Avoid such errors by using the 
following resources: 
How to Administer Intramuscular 
(IM) and Subcutaneous (SC) 
Injections  
http://www.immunize.org/catg.d/p2
020.pdf  
How to Administer IM and SC 
Injections to Adults  
http://www.immunize.org/catg.d/p2
020a.pdf 
Administering Vaccines to Adults: 
Dose, Route, Site, Needle Size, and 
Preparation 
http://www.immunize.org/catg.d/p3
084.pdf  
Administering Vaccines: Dose, 
Route, Site, and Needle Size 
(includes all vaccines) 
http://www.immunize.org/catg.d/p3
085.pdf 
This question/answer is re-printed 
from the Immunization Action 
Coalition “Ask the Experts” site.  
http://www.immunize.org/askexpert
s/ 
Training Announcements  
Immunization Update 2009  Mark your calendars for the July 30, 2009 
Live Satellite Broadcast and Webcast from CDC’s National Center for 
Immunization and Respiratory Diseases 
(NCIRD).  
The event will take place from 9:00 AM – 
11:30 AM and noon – 2:30 PM EST. More 
information about this broadcast will soon be 
available at the CDC Vaccine Education and 
Training Web page. 
Epidemiology & Prevention of Vaccine-
Preventable Diseases is a comprehensive 
overview of the principles of vaccination, 
general recommendations, immunization 
strategies for providers, and specific 
information about vaccine-preventable 
diseases and the vaccines that prevent them. This program can be watched 
via the web or ordered on DVD.  It is a 12 hour course with four 3-hour 
sessions.  For more information on go to the following CDC Web site: 
http://www.cdc.gov/vaccines/ed/epivac/default.htm 
Change in VIS Guidelines, continued 
